Introduction: Almost all patients treated with opioids suffer from con
stipation. Numerous laxatives are used to overcome the problem, but no
ne has yet been found to yield favourable results in all patients. Sev
eral studies have attempted to reverse opioid-induced constipation by
the use of oral naloxone. Experiments carried out in rats showed that
morphine-induced constipation is reduced by oral naloxone without impa
irment of antinociception [4]. However, evaluation of clinical studies
reveals that there is uncertainty about the dosage regimen (the daily
dose of naloxone ranged from 0.5% to about 60% that of morphine) and
a lack of larger numbers of patients studied. Methods: Fifteen patient
s suffering from opioid-induced constipation participated in the prese
nt study. (1)Constipation had been present for 5 to 14 days despite th
e use of laxatives. According to the results obtained in the animal ex
periments [4], it was originally planned to administer oral naloxone a
t a dose ratio of 1:1 with respect to morphine on day 1 and 2; reducin
g it on day 3 and 4 to one-half and then to one-fourth of the initial
dose on day 5 and 6. Results: Twelve patients experienced a strong lax
ative effect with spontaneous bowel evacuation 1 to 4 h after the firs
t intake of oral naloxone. Three patients had no laxative effects even
after repeated doses. Eleven of the 15 patients reported an average l
oss of 10%-15% of analgesia after oral naloxone as measured by visual
analogue scales. Increasing the morphine dose by about 15% restored th
e previous level of analgesia without reappearance of constipation. Ei
ght of the 12 patients having a laxative effect experienced abdominal
cramps, and therefore, the total dose of naloxone was reduced on day 2
to 2%-15% of that originally planned; this dose still produced a laxa
tive effect. Four of the 15 patients had a withdrawal syndrome. A sing
le dose of morphine equivalent to their daily morphine intake abolishe
d the symptoms. Discussion: The medical history of the 3 patients in w
hom naloxone failed to abolish constipation revealed neurological dist
urbances. Treatment of these patients included the use of neuroleptics
, antiemetics, and other drugs. In this context, it should be noted th
at oral naloxone can be expected to abolish only opioid-induced consti
pation. In conclusion, it was found that the treatment of opioid-induc
ed constipation by administration of oral naloxone produced positive r
esults. A controlled study will show, whether the side effects can be
minimized by reducing the naloxone dose.